What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain [...]
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli [...]
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s
People with two copies of the gene variant APOE4 are [...]
New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Decline
A trial of donanemab, an experimental drug, found it modestly [...]